Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma

British Journal of Haematology

Volumn 125, Issue 1, 2004, Pages 38-41

  Hashimoto, Toshihiro ^a   Abe, Masahiro ^a   Oshima, Takashi ^a   Shibata, Hironobu ^a   Ozaki, Shuji ^b   Inoue, Daisuke ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bone disease; Chemokines; Multiple myeloma

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; DEOXYPYRIDINOLINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; BONE TURNOVER; CLINICAL ARTICLE; CORRELATION FUNCTION; CYTOKINE RELEASE; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; MYELOMA CELL; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SECRETION;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOCALCIN; OSTEOLYSIS; TUMOR CELLS, CULTURED;

EID: 1842505726     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04864.x     Document Type: Article

References (12)

1. Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D. & Matsumoto, T. (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood, 100, 2195-2202.
2. Alexandrakis, M.G., Passam, F.H., Malliaraki, N., Katachanakis, C., Kyriakou, D.S. & Margioris, A.N. (2002) Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clinica Chimica Acta, 325, 51-57.
3. Barille, S., Collette, M., Bataille, R. & Amiot, M. (1995) Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood, 86, 3151-3159.
4. Choi, S.J., Cruz, J.C., Craig, F., Chung, H., Devlin, R.D., Roodman, G.D. & Alsina, M. (2000) Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood, 96, 671-675.
5. Choi, S.J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J. & Roodman, G.D. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. Journal of Clinical Investigation, 108, 1833-1841.
6. Goto, T., Kennel, S.J., Abe, M., Takishita, M., Kosaka, M., Solomon, A. & Saito, S. (1994) A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood, 84, 1922-1930.
7. Han, J.H., Choi, S.J., Kurihara, N., Koide, M., Oba, Y. & Roodman, G.D. (2001) Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood, 97, 3349-3353.
8. Khosla, S. & Kleerekoper, M. (2003) Biochemical markers of bone turnover. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (ed. by M.J. Favus), pp. 166-172. American Society for Bone and Mineral Research, Washington, DC.
9. Ozaki, S., Kosaka, M., Wakatsuki, S., Abe, M., Koishihara, Y. & Matsumoto, T. (1997) Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood, 90, 3179-3186.
10. Pecherstorfer, M., Seibel, M.J., Woitge, H.W., Horn, E., Schuster, J., Neuda, J., Sagaster, P., Kohn, H., Bayer, P., Thiebaud, D. & Ludwig, H. (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood, 90, 3743-3750.
11. Roodman, G.D. (1997) Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer, 80, 1557-1563.
12. Uneda, S., Hata, H., Matsuno, F., Harada, N., Mitsuya, Y., Kawano, F. & Mitsuya, H. (2003) Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. British Journal of Haematology, 120, 53-55.